Skip to main content
Wed, Mar 18, 2026
S&P 500 5,142.30 +0.87%|NASDAQ 16,284.75 +1.12%|DOW 38,972.10 -0.23%|AAPL $192.45 +1.80%|TSLA $241.80 -2.10%|AMZN $178.92 +0.54%|GOOGL $141.20 +0.32%|MSFT $415.60 -0.15%|
S&P 500 5,142.30 +0.87%|NASDAQ 16,284.75 +1.12%|DOW 38,972.10 -0.23%|AAPL $192.45 +1.80%|TSLA $241.80 -2.10%|AMZN $178.92 +0.54%|GOOGL $141.20 +0.32%|MSFT $415.60 -0.15%|
HealthCanada1 sourcesNeutral

Apixaban Safer Than Rivaroxaban for Treatment of Acute Venous Thromboembolism - Pulmonology Advisor

Apixaban Safer Than Rivaroxaban for Treatment of Acute Venous Thromboembolism Pulmonology Advisor Blood-thinning drug Eliquis likely safer for patients with deep blood clots, study suggests CBC Ottawa Hospital research finds ‘clear winner’ for safer blood clot treatment CTV News

Google News
via Google News

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Comments

0 comments
Be respectful and constructive.
Loading comments...